Clinical Trial Update: Drug-Drug Interaction Study in Healthy Subjects [Phase 1]

View source ↗

Summary

This is a completed Phase 1 drug–drug interaction study in healthy subjects sponsored by Bristol-Myers Squibb for a Hepatitis C program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED